180 related articles for article (PubMed ID: 33682590)
1. Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis.
Jena A; Jha DK; Kumar-M P; Kasudhan KS; Kumar A; Sarwal D; Mishra S; Singh AK; Bhatia P; Patil A; Sharma V
Expert Rev Clin Pharmacol; 2021 Apr; 14(4):491-501. PubMed ID: 33682590
[No Abstract] [Full Text] [Related]
2. Time to incorporate preemptive NUDT15 testing before starting thiopurines in inflammatory bowel disease in Asia and beyond: a review.
Desai D; Jena A; Sharma V; Hibi T
Expert Rev Clin Pharmacol; 2023; 16(7):643-653. PubMed ID: 37387532
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.
Hindorf U; Lindqvist M; Peterson C; Söderkvist P; Ström M; Hjortswang H; Pousette A; Almer S
Gut; 2006 Oct; 55(10):1423-31. PubMed ID: 16543290
[TBL] [Abstract][Full Text] [Related]
4. ITPA polymorphisms do not predict additional risk beyond TPMT and NUDT15 for thiopurine-induced cytopenia in inflammatory bowel disease.
Jena A; Grover N; Bhatia P; Singh M; Lad D; Prasad KK; Singh H; Dutta U; Sharma V
Rev Gastroenterol Mex (Engl Ed); 2024; 89(1):25-30. PubMed ID: 36707393
[TBL] [Abstract][Full Text] [Related]
5. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
Maillard M; Nishii R; Yang W; Hoshitsuki K; Chepyala D; Lee SHR; Nguyen JQ; Relling MV; Crews KR; Leggas M; Singh M; Suang JLY; Yeoh AEJ; Jeha S; Inaba H; Pui CH; Karol SE; Trehan A; Bhatia P; Antillon Klussmann FG; Bhojwani D; Haidar CE; Yang JJ
J Natl Cancer Inst; 2024 May; 116(5):702-710. PubMed ID: 38230823
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation.
Díaz-Villamarín X; Fernández-Varón E; Rojas Romero MC; Callejas-Rubio JL; Cabeza-Barrera J; Rodríguez-Nogales A; Gálvez J; Morón R
Biomed Pharmacother; 2023 Dec; 168():115706. PubMed ID: 37857254
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Yu N; Sriranganathan D; Walker GJ; Sazonovs A; Wilding H; Roberts C; Kennedy NA; Ahmad T; Boyapati RK; Ding NS; Segal JP
J Crohns Colitis; 2023 Dec; 17(12):1920-1930. PubMed ID: 37346013
[TBL] [Abstract][Full Text] [Related]
8. Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients.
Sabirova Z; Mahnoor S; Lasfar D; Gagné V; Théorêt Y; Leclerc JM; Laverdière C; Sinnett D; Tran TH; Krajinovic M
Pharmacogenet Genomics; 2024 Jul; 34(5):170-173. PubMed ID: 38682355
[TBL] [Abstract][Full Text] [Related]
9. Novel variants in
Moriyama T; Yang YL; Nishii R; Ariffin H; Liu C; Lin TN; Yang W; Lin DT; Yu CH; Kham S; Pui CH; Evans WE; Jeha S; Relling MV; Yeoh AE; Yang JJ
Blood; 2017 Sep; 130(10):1209-1212. PubMed ID: 28659275
[TBL] [Abstract][Full Text] [Related]
10. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia.
Yang SK; Hong M; Baek J; Choi H; Zhao W; Jung Y; Haritunians T; Ye BD; Kim KJ; Park SH; Park SK; Yang DH; Dubinsky M; Lee I; McGovern DP; Liu J; Song K
Nat Genet; 2014 Sep; 46(9):1017-20. PubMed ID: 25108385
[TBL] [Abstract][Full Text] [Related]
11. Early proactive monitoring of DNA-thioguanine in patients with Crohn's disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers.
Yang T; Chao K; Zhu X; Wang XD; Chan S; Guan YP; Mao J; Li P; Guan SX; Xie W; Gao X; Huang M
World J Gastroenterol; 2024 Mar; 30(12):1751-1763. PubMed ID: 38617736
[TBL] [Abstract][Full Text] [Related]
12. Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study.
Makuuchi M; Kakuta Y; Umeno J; Fujii T; Takagawa T; Ibuka T; Miura M; Sasaki Y; Takahashi S; Nakase H; Kiyohara H; Tominaga K; Shimodaira Y; Hiraoka S; Ueno N; Yanai S; Yoshihara T; Kakimoto K; Matsuoka K; Hayashi R; Nanjo S; Iwama I; Ishiguro Y; Chiba H; Endo K; Kagaya T; Fukuda T; Sakata Y; Kudo T; Takagi T; Takahashi K; Naganuma M; Shinozaki M; Ogata N; Tanaka H; Narimatsu K; Miyazaki H; Ishige T; Onodera M; Hashimoto Y; Nagai H; Shimoyama Y; Naito T; Moroi R; Shiga H; ; Kinouchi Y; Andoh A; Hisamatsu T; Masamune A
J Gastroenterol; 2024 Jun; 59(6):468-482. PubMed ID: 38589597
[TBL] [Abstract][Full Text] [Related]
13. Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients.
Kennedy AM; Griffiths AM; Muise AM; Walters TD; Ricciuto A; Huynh HQ; Wine E; Jacobson K; Lawrence S; Carman N; Mack DR; deBruyn JC; Otley AR; Deslandres C; El-Matary W; Zachos M; Benchimol EI; Critch J; Schneider R; Crowley E; Li M; Warner N; McGovern DPB; Li D; Haritunians T; Rudin S; Cohn I
Inflamm Bowel Dis; 2024 May; ():. PubMed ID: 38788739
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of personalized versus standard initial dosing of thiopurines: Systematic review and meta-analysis of randomized trials.
Jena A; Birda CL; Choudhury A; Sharma V
Expert Opin Drug Saf; 2023; 22(12):1253-1263. PubMed ID: 37436005
[TBL] [Abstract][Full Text] [Related]
15. Association of
Du S; Huang X; He X; Mao M; Chen M; Zhang R; Shao H; Lv Z; Liu X; Chuan J
Haematologica; 2024 Apr; 109(4):1053-1068. PubMed ID: 37794799
[TBL] [Abstract][Full Text] [Related]
16. Association Between Genetically Predicted Expression of TPMT and Azathioprine Adverse Events.
Davis A; Dickson AL; Daniel LL; Nepal P; Zanussi J; Miller-Fleming TW; Straub PS; Wei WQ; Liu G; Cox NJ; Hung AM; Feng Q; Stein CM; Chung CP
Res Sq; 2023 Jan; ():. PubMed ID: 36711487
[TBL] [Abstract][Full Text] [Related]
17. 6-Mercaptopurine-Associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report.
Voelz K; Miller G; Lee-Miller C
J Pediatr Hematol Oncol; 2024 May; ():. PubMed ID: 38775421
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]